Office Headquarters: (610) 544-3500

perirx log in button

PeriRx Logo


Get News and Updates



CLIA: 39D2085645

PeriRx on Facebook PeriRx on YouTube PeriRx on Google+ Stephen M. Swanick LinkedIn


New York State has a separate and unique regulatory approval process for laboratory diagnostic testing. PeriRx is currently in the application process with our SaliMark™ OSCC test and is vigorously committed to pursuing this application approval. 

Oral Cancer Awareness – Supplement of RDH Magazine

Oral Cancer AwarenessFor more than half a century, oral and oropharyngeal cancers have been out of the mainstream view of the American public, have seen their death rate remain unchanged, and until recently had no national early discovery effort directed at them. The morbidity of treatments — that the roughly 59% who survive five years after diagnosis experience — is significant, (a death rate significantly worse than other cancers whose names are more commonly recognized), and leaves patients with serious quality of life issues that only get worse each year as they move further into survivorship. There are many ways in which this paradigm can be improved, and we are on the cusp of several opportunities to change much of this. [Read more…]